angiotensin ii has been researched along with amastatin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (32.14) | 18.7374 |
| 1990's | 15 (53.57) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, KL; Cunoosamy, MP; Robertson, MJ | 1 |
| Johnson, AK; Sullivan, MJ | 1 |
| Barnes, JC; Hawcock, AB; Michel, AD | 1 |
| Ardaillou, N; Ardaillou, R; Stefanovic, V; Vlahovic, P | 1 |
| Kasugai, M; Kurauchi, O; Mizutani, S; Narita, O; Nomura, S; Tomoda, Y | 1 |
| Batt, CM; Hanesworth, JM; Harding, JW; Jensen, LL; Wright, JW | 1 |
| Beltz, TG; Johnson, AK; Sullivan, MJ | 1 |
| Cook, VI; Harding, JW; Murray, CE; Roberts, KA; Sardinia, MF; Wright, JW | 1 |
| Drummer, OH; Johnson, H; Kourtis, S | 1 |
| Harding, JW; Jensen, LL; Wright, JW | 1 |
| Harding, JW; Sullivan, MJ; Wright, JW | 1 |
| Batt, CM; Harding, JW; Klein, EW; Wright, JW | 1 |
| Felix, D; Harding, JW; Imboden, H | 1 |
| Dewey, AL; Hanesworth, JM; Harding, JW; Wright, JW | 1 |
| Harding, JW; Quirk, WS; Wright, JW | 1 |
| Abhold, RH; Harding, JW; Sullivan, MJ; Wright, JW | 1 |
| Denef, C; Schramme, C | 1 |
| Hashimoto, T; Kawashima, Y; Kobayashi, H; Mizutani, S; Sakura, H; Sakura, N | 1 |
| Dampney, RA; Li, YW; Sasaki, S | 1 |
| Appenrodt, E; Brattström, A | 1 |
| Sim, MK | 1 |
| Li, Q; Pfaffendorf, M; van Zwieten, PA; Zhang, J | 1 |
| Eijsman, L; Feenstra, M; Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
| Cerullo, G; Colucci, M; Gesualdo, L; Grandaliano, G; Monno, R; Ranieri, E; Rossiello, MR; Schena, FP; Semeraro, N; Ursi, M | 1 |
| Ito, S; Sved, AF | 1 |
| Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
| de Godoy, MA; de Oliveira, AM; Rattan, S | 1 |
| Guethe, LM; Juliano, MA; Martins, AR; Pelegrini-da-Silva, A; Prado, WA; Rosa, E | 1 |
28 other study(ies) available for angiotensin ii and amastatin
| Article | Year |
|---|---|
Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
Topics: 3-Mercaptopropionic Acid; Adrenergic alpha-Agonists; Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Leucine; Male; Molecular Sequence Data; Muscle Contraction; Oligopeptides; Peptides; Phenylephrine; Rabbits; Receptors, Angiotensin; Vasoconstriction | 1992 |
Amastatin potentiates drinking elicited by osmotic stimuli: evidence for peptidergic mediation of intracellular dehydration-induced thirst.
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Dehydration; Drinking; Endopeptidases; Glutamyl Aminopeptidase; Injections, Intraventricular; Male; Neuropeptides; Oligopeptides; Osmolar Concentration; Peptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Thiorphan; Thirst | 1992 |
Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.
Topics: Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Bacitracin; Biphenyl Compounds; Dithiothreitol; Ganglia, Sympathetic; Imidazoles; In Vitro Techniques; Losartan; Male; Neuromuscular Depolarizing Agents; Oligopeptides; Peptides; Protease Inhibitors; Rats; Tetrazoles | 1992 |
Receptor-mediated induction of aminopeptidase A (APA) of human glomerular epithelial cells (HGEC) by glucocorticoids.
Topics: Aldosterone; Aminopeptidases; Angiotensin II; Anti-Bacterial Agents; Calcium; Cycloheximide; Dactinomycin; Dexamethasone; Enzyme Induction; Epithelium; Glucocorticoids; Glutamyl Aminopeptidase; Humans; Kidney Glomerulus; Mifepristone; Oligopeptides; Peptides; Receptors, Glucocorticoid | 1991 |
Effects of low molecular weight peptides and divalent cations on degradation and binding of angiotensin II.
Topics: Adult; Aminopeptidases; Angiotensin II; Anti-Bacterial Agents; Cations, Divalent; Cobalt; Female; Humans; In Vitro Techniques; Iodine Radioisotopes; Leucine; Molecular Weight; Oligopeptides; Peptides; Placenta; Pregnancy | 1990 |
Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
Topics: 3-Mercaptopropionic Acid; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Carboxypeptidases; Cerebral Ventricles; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
Amastatin potentiation of drinking induced by blood-borne angiotensin: evidence for mediation by endogenous brain angiotensin.
Topics: Aminopeptidases; Angiotensin II; Animals; Anti-Bacterial Agents; Carbachol; Drinking Behavior; Drug Interactions; Enzyme Inhibitors; Glutamyl Aminopeptidase; Injections, Intraventricular; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains | 1990 |
Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains | 1990 |
Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Enalapril; Kidney; Neprilysin; Oligopeptides; Peptide Fragments; Peptides; Rats; Rats, Inbred WKY; Thiorphan | 1990 |
Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
Topics: Aminopeptidases; Angiotensin II; Animals; Anti-Bacterial Agents; Blood Pressure; Brain; Enzyme Inhibitors; Hypertension; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Angiotensin | 1989 |
Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Cerebral Ventricles; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains; Reference Values | 1988 |
Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
Topics: Aminopeptidases; Angiotensin II; Animals; Anti-Bacterial Agents; Blood Pressure; Brain; Carboxypeptidases; Enzyme Inhibitors; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains; Receptors, Angiotensin | 1988 |
The hypothalamic-angiotensin system: location and functional considerations.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Immunohistochemistry; Iontophoresis; Leucine; Male; Oligopeptides; Paraventricular Hypothalamic Nucleus; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1988 |
Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
Topics: Aminopeptidases; Angiotensin II; Animals; Anti-Bacterial Agents; Cerebral Ventricles; Enzyme Inhibitors; Half-Life; Injections, Intraventricular; Iodine Radioisotopes; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains | 1988 |
Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
Topics: Aminopeptidases; Angiotensin II; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drinking Behavior; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains | 1987 |
Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Iodine Radioisotopes; Leucine; Male; Oligopeptides; Peptides; Rats; Rats, Inbred Strains | 1987 |
Stimulation of spontaneous and dopamine-inhibited prolactin release from anterior pituitary reaggregate cell cultures by angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Animals; Anti-Bacterial Agents; Captopril; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Male; Oligopeptides; Peptides; Pituitary Gland, Anterior; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains | 1984 |
Kinetic properties of placental aminopeptidase A: N-terminal degradation of angiotensin II.
Topics: Amino Acids; Aminopeptidases; Angiotensin II; Anti-Bacterial Agents; Aspartic Acid; Cations, Divalent; Female; Glutamyl Aminopeptidase; Humans; Kinetics; Oligopeptides; Peptides; Placenta; Pregnancy | 1983 |
Comparison of the pressor effects of angiotensin II and III in the rostral ventrolateral medulla.
Topics: Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Histocytochemistry; Horseradish Peroxidase; Leucine; Medulla Oblongata; Microinjections; Oligopeptides; Peptides; Rabbits; Sodium; Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate; Wheat Germ Agglutinins | 1993 |
Effects of central angiotensin II and angiotensin III on baroreflex regulation.
Topics: Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Baroreflex; Blood Pressure; Drinking; Heart Rate; Injections, Intraventricular; Male; Nitroprusside; Peptides; Phenylephrine; Rats; Rats, Wistar | 1994 |
Degradation of angiotensin I in the endothelium and smooth muscle of the rat aorta.
Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Aorta; Endothelium, Vascular; Leucine; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligopeptides; Peptides; Rats; Rats, Sprague-Dawley | 1993 |
Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Decerebrate State; Heart Atria; Heart Rate; In Vitro Techniques; Injections, Intravenous; Male; Peptides; Prazosin; Propranolol; Rats; Rats, Wistar; Stimulation, Chemical; Vasoconstrictor Agents | 1996 |
Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
Topics: Aged; Aged, 80 and over; Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutamyl Aminopeptidase; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Metalloendopeptidases; Methionyl Aminopeptidases; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Peptides; Protease Inhibitors; Pyridines; Saphenous Vein; Tachyphylaxis; Tetrazoles; Vasoconstrictor Agents | 1997 |
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Blotting, Northern; Cell Division; Cell Line, Transformed; Epithelial Cells; Fibrosis; Gene Expression; Humans; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Peptides; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor beta; Urokinase-Type Plasminogen Activator | 1999 |
Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; GABA Antagonists; Losartan; Male; Medulla Oblongata; Muscimol; Peptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents | 2000 |
Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents | 2001 |
Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.
Topics: Adenine; Angiotensin II; Animals; Blotting, Western; CD13 Antigens; Drug Interactions; Glutamyl Aminopeptidase; Imidazoles; Losartan; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Peptides; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrodotoxin; Thiorphan | 2004 |
Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter.
Topics: Analgesics; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Disease Models, Animal; Drug Interactions; Efferent Pathways; Glutamyl Aminopeptidase; Losartan; Male; Microinjections; Neural Inhibition; Nociceptors; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptides; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Angiotensin | 2009 |